DSM PTG Hires its 100th employee as its business continues to expand
Last year the Polymer Technology Group became part of DSM Biomedical. Through this acquisition, the combined companies have achieved a leading position in the field of long-term implantable biomedical polymers along with a technology platform that is applicable to numerous additional materials to address the therapeutic needs of the medical technology industry--ranging from coatings to biomedical materials to drug delivery platforms.
“We are extremely pleased that the robust growth of our biomaterials and medical device components business continues to result in the need for further expansion of our operations, including the hiring of new employees,” said Bob Ward, CEO of DSM PTG. “The combined portfolios of the former Polymer Technology Group and DSM Biomedical have resulted in the broadest portfolio of biomedical materials currently available in the worldwide market, and we are very bullish about our future.”
Frederik G. Hoogendijk was previously Director of Finance & Control for DSM Fine Chemicals since 2006. He has held a variety of financial control positions with increasing responsibility across several DSM-owned businesses since 1996. He holds a master's degree in business economics from Erasmus University (Rotterdam, the Netherlands).
Robert F. Evans was previously Global Sales & Marketing Manager for DSM Dyneema since 2006. He has held a variety of marketing and sales positions with increasing responsibility across several DSM-owned businesses since 1996. He holds an MBA from the University of Southern Indiana (Evansville) and a bachelor's degree in chemistry from George Mason University (Fairfax, Va.).